STAT

‘We, as a society, should be outraged’: a conversation about public health

Leading figures in health and medicine sound an alarm about growing disparities between rich and poor, lack of scientific literacy in the public, and more.

STAT’s flagship newsletter has been getting readers ahead of the day’s health news for two years — and to celebrate, we convened a group of experts in the Boston area to talk about the most pressing issues in health and medicine.

Our panel: Dr. Sandro Galea, dean of the Boston University School of Public Health; Kate Walsh, president and CEO of Boston Medical Center; Mary Tolikas, engineer and operations director of the Wyss Institute at Harvard; and Dr. Harris Berman, dean of Tufts University School of Medicine.

The following excerpts have been lightly edited and grouped

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.

Related Books & Audiobooks